Clinical trials for Crohn's disease

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Crohn's disease. For all clinical trials, go to clinical trials search

This list shows clinical trials for Crohn's disease

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Crohn's disease
Title Recruitment status Location
Antibiotics and Hydroxychloroquine in Crohn's Recruiting United Kingdom
Entyvio (Vedolizumab) Long Term Safety Study Recruiting United Kingdom
A Study of the Safety and Efficacy of Etrolizumab in Patients With Moderately to Severely Active Crohn's Disease Recruiting United Kingdom
Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 Recruiting United Kingdom
Assessing the length of Crohn's resection on disease recurrence Recruiting United Kingdom
MOlecular BIomarkers and Adherent and Invasive Escherichia Coli (AIEC) Detection Study In Crohn's Disease Patients Recruiting United Kingdom
Evaluation of Efficacy and Safety of MEDI2070 in Subjects With Active, Moderate to Severe Crohn's Disease Recruiting United Kingdom
Adverse Effects of Glucocorticoid Therapy on Bone in Childhood Crohn's Disease Recruiting United Kingdom
A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease Recruiting United Kingdom
A Phase II, Multicenter, Randomized, Double-blind, Multiple Dose, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Pharmacokinetics, and Safety of BI 655066, an IL-23 p19 Antagonist Monoclonal Antibody, in Patients With Moderately to Severely Active Crohn's Disease, Who Are naïve to, or Were Previously Treated With Anti-TNF Therapy. Recruiting United Kingdom

Page last reviewed: 17/04/2015

Next review due: 01/04/2018